Maturation of Oxycodone Pharmacokinetics in Neonates and Infants: a Population Pharmacokinetic Model of Three Clinical Trials

被引：0
|
作者：
Pyry Välitalo
Merja Kokki
Veli-Pekka Ranta
Klaus T. Olkkola
Andrew C. Hooker
Hannu Kokki
机构：
[1] Leiden University,Division of Pharmacology
[2] Kuopio University Hospital,Department of Anesthesia and Operative Services
[3] University of Eastern Finland,School of Medicine
[4] University of Eastern Finland,School of Pharmacy
[5] University of Helsinki and Helsinki University Hospital,Department of Anesthesiology, Intensive Care and Pain Medicine
[6] Uppsala University,Department of Pharmaceutical Biosciences
来源：
Pharmaceutical Research | 2017年 / 34卷
关键词：
analgesic, opioid; infant, extremely premature; oxycodone; pain; pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1125 / 1133
页数：8
相关论文
共 50 条
  • [1] Maturation of Oxycodone Pharmacokinetics in Neonates and Infants: a Population Pharmacokinetic Model of Three Clinical Trials
    Valitalo, Pyry
    Kokki, Merja
    Ranta, Veli-Pekka
    Olkkola, Klaus T.
    Hooker, Andrew C.
    Kokki, Hannu
    PHARMACEUTICAL RESEARCH, 2017, 34 (05) : 1125 - 1133
  • [2] Maturation of oxycodone pharmacokinetics in neonates and infants: Oxycodone and its metabolites in plasma and urine
    Kokki, Merja
    Heikkinen, Marja
    Valitalo, Pyry
    Hautajarvi, Heidi
    Hokkanen, Juho
    Pitkanen, Hanna
    Sankilampi, Ulla
    Ranta, Veli-Pekka
    Kokki, Hannu
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (04) : 791 - 800
  • [3] Population pharmacokinetics of oxycodone: Premature neonates to adults
    Morse, James D.
    Sundermann, Milan
    Hannam, Jacqueline A.
    Kokki, Hannu
    Kokki, Merja
    Anderson, Brian J.
    PEDIATRIC ANESTHESIA, 2021, 31 (12) : 1332 - 1339
  • [4] Population pharmacokinetics of propofol in neonates and infants: Gestational and postnatal age to determine clearance maturation
    Sandra, Louis
    Smits, Anne
    Allegaert, Karel
    Nicolai, Johan
    Annaert, Pieter
    Bouillon, Thomas
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (04) : 2089 - 2097
  • [5] Population Pharmacokinetics of Ketorolac in Neonates and Young Infants
    Zuppa, Athena F.
    Mondick, John T.
    Davis, Lisa
    Cohen, David
    AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (02) : 143 - 146
  • [6] Population Pharmacokinetic Analysis of Digoxin in Chinese Neonates and Infants
    Gong, Yan
    Chen, Yewei
    Li, Qin
    Li, Zhiping
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 125 (02) : 142 - 149
  • [7] Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants
    Tang, Bo-Hao
    Wu, Yue-E
    Kou, Chen
    Qi, Yu-Jie
    Qi, Hui
    Xu, Hai-Yan
    Leroux, Stephanie
    Huang, Xin
    Zhou, Yue
    Zheng, Yi
    Jacqz-Aigrain, Evelyne
    Shen, A-Dong
    Zhao, Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (02)
  • [8] Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease
    Su, Felice
    El-Komy, Mohammed H.
    Hammer, Gregory B.
    Frymoyer, Adam
    Cohane, Carol A.
    Drover, David R.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2015, 36 (02) : 104 - 114
  • [9] Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants
    Zhao, Yang
    Yao, Bu-Fan
    Kou, Chen
    Xu, Hai-Yan
    Tang, Bo-Hao
    Wu, Yue-E
    Hao, Guo-Xiang
    Zhang, Xin-Ping
    Zhao, Wei
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [10] Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates
    Stockmann C.
    Hersh A.L.
    Roberts J.K.
    Bhongsatiern J.
    Korgenski E.K.
    Spigarelli M.G.
    Sherwin C.M.T.
    Frymoyer A.
    Infectious Diseases and Therapy, 2015, 4 (2) : 187 - 198
12345